Neurological Impacts of Artificial Sweeteners in the Context of Diet Sodas

Sponsor
Beth Israel Deaconess Medical Center (Other)
Overall Status
Completed
CT.gov ID
NCT04048681
Collaborator
(none)
5
1
3
4.5
1.1

Study Details

Study Description

Brief Summary

This study seeks to determine whether artificial sweeteners in the context of diet soda may alter the brain's response to food cues and thus impact appetite.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: diet soda
  • Behavioral: Regular soda
  • Behavioral: Carbonated Water
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
5 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Masking:
None (Open Label)
Primary Purpose:
Other
Official Title:
Neurological Impacts of Artificial Sweeteners in the Context of Diet Sodas
Actual Study Start Date :
Aug 6, 2019
Actual Primary Completion Date :
Dec 20, 2019
Actual Study Completion Date :
Dec 20, 2019

Arms and Interventions

Arm Intervention/Treatment
Experimental: Diet Soda

12oz can of Diet Coke

Behavioral: diet soda
12 oz can of artificially sweetened cola beverage (Diet Coke planned to be used but similar to Diet Pepsi or other Diet Colas)
Other Names:
  • Diet Coke
  • Diet Pepsi
  • Active Comparator: Soda

    12oz can of Coke

    Behavioral: Regular soda
    12oz can of regular cola beverage (Coke planned but similar to Pepsi or other regular cola sodas)
    Other Names:
  • Coke
  • Pepsi
  • Placebo Comparator: Carbonated Water

    12oz can of carbonated (unflavored) water

    Behavioral: Carbonated Water
    12oz can of carbonated water (sparking water, selzter water) unflavored

    Outcome Measures

    Primary Outcome Measures

    1. Changes in Brain Response to Food Cues in the Insula [1 hour]

      Functional magnetic resonance imaging (BOLD signals) while patients view food vs. non-food cues. The effect size z-score represents the magnitude of the activation in that area to food cues vs. non-food cues. The z-score is the estimated response magnitude in that area compared to the overall mean. Negative numbers indicate values lower than the mean and positive numbers indicate values above the mean.

    Secondary Outcome Measures

    1. Neurocognitive Testing (Stop Signal Reaction Time) [1 hour]

      stop signal reaction time is a measure of inhibitory control, where a shorter stop signal reaction time indicates greater inhibitory control.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 65 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Men and women who are 18-65 years old, with a BMI >30kg/m2.
    Exclusion Criteria:
    • Unable or unwilling to participate in the study for any reason

    • Metal in the body or other safety concerns which makes patient unable to have an MRI

    • Pregnant women will be excluded to protect the fetus against potential effects of a non-medically required MRI on fetal development and difficulty of measuring accurate BMI.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Beth Israel Deaconess Medical Center MRI Research Facility Boston Massachusetts United States 02215

    Sponsors and Collaborators

    • Beth Israel Deaconess Medical Center

    Investigators

    None specified.

    Study Documents (Full-Text)

    More Information

    Publications

    None provided.
    Responsible Party:
    Olivia Farr, Instructor in Medicine, Beth Israel Deaconess Medical Center
    ClinicalTrials.gov Identifier:
    NCT04048681
    Other Study ID Numbers:
    • 2019P000649
    First Posted:
    Aug 7, 2019
    Last Update Posted:
    Feb 5, 2020
    Last Verified:
    Jan 1, 2020
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Olivia Farr, Instructor in Medicine, Beth Israel Deaconess Medical Center
    Additional relevant MeSH terms:

    Study Results

    Participant Flow

    Recruitment Details
    Pre-assignment Detail This is a cross-over trial, and participants were assigned to receive diet soda, regular soda, and carbonated water in a random order.
    Arm/Group Title Diet Soda Then Regular Soda Then Carbonated Water Regular Soda Then Carbonated Water Then Diet Soda Carbonated Water Then Diet Soda Then Regular Soda Regular Soda Then Diet Soda Then Carbonated Water Diet Soda Then Carbonated Water Then Regular Soda
    Arm/Group Description Participant had first visit with 12oz can of diet soda, 7 days washout, then second visit with 12 oz can of regular soda, 7 days washout, then third visit with 12 oz can of carbonated water. Participant had first visit with 12oz can of regular soda, 7 days washout, then second visit with 12 oz can of carbonated water, 7 days washout, then third visit with 12 oz can of diet soda. Participant had first visit with 12oz can of carbonated water, 7 days washout, then second visit with 12 oz can of diet soda, 7 days washout, then third visit with 12 oz can of regular soda. Participant had first visit with 12oz can of regular soda, 7 days washout, then second visit with 12 oz can of diet soda, 7 days washout, then third visit with 12 oz can of carbonated water. Participant had first visit with 12oz can of diet soda, 7 days washout, then second visit with 12 oz can of carbonated water, 7 days washout, then third visit with 12 oz can of regular soda.
    Period Title: Overall Study
    STARTED 1 1 1 1 1
    COMPLETED 1 1 1 0 1
    NOT COMPLETED 0 0 0 1 0

    Baseline Characteristics

    Arm/Group Title Diet Soda/Regular Soda/ Carbonated Water
    Arm/Group Description The same subjects participated in all three conditions.
    Overall Participants 5
    Age (years) [Mean (Standard Deviation) ]
    Mean (Standard Deviation) [years]
    51.6
    (14.1)
    Sex: Female, Male (Count of Participants)
    Female
    2
    40%
    Male
    3
    60%
    Ethnicity (NIH/OMB) (Count of Participants)
    Hispanic or Latino
    1
    20%
    Not Hispanic or Latino
    4
    80%
    Unknown or Not Reported
    0
    0%
    Race (NIH/OMB) (Count of Participants)
    American Indian or Alaska Native
    0
    0%
    Asian
    0
    0%
    Native Hawaiian or Other Pacific Islander
    0
    0%
    Black or African American
    2
    40%
    White
    3
    60%
    More than one race
    0
    0%
    Unknown or Not Reported
    0
    0%
    Body Mass Index (BMI) (kg/m^2) [Mean (Standard Deviation) ]
    Mean (Standard Deviation) [kg/m^2]
    36.1
    (5.4)

    Outcome Measures

    1. Primary Outcome
    Title Changes in Brain Response to Food Cues in the Insula
    Description Functional magnetic resonance imaging (BOLD signals) while patients view food vs. non-food cues. The effect size z-score represents the magnitude of the activation in that area to food cues vs. non-food cues. The z-score is the estimated response magnitude in that area compared to the overall mean. Negative numbers indicate values lower than the mean and positive numbers indicate values above the mean.
    Time Frame 1 hour

    Outcome Measure Data

    Analysis Population Description
    [Not Specified]
    Arm/Group Title Diet Soda Soda Carbonated Water
    Arm/Group Description 12oz can of Diet Coke diet soda: 12 oz can of artificially sweetened cola beverage (Diet Coke planned to be used but similar to Diet Pepsi or other Diet Colas) 12oz can of Coke Regular soda: 12oz can of regular cola beverage (Coke planned but similar to Pepsi or other regular cola sodas) 12oz can of carbonated (unflavored) water Carbonated Water: 12oz can of carbonated water (sparking water, selzter water) unflavored
    Measure Participants 5 5 4
    Mean (Standard Error) [z-score]
    0.25
    (0.3)
    -0.9
    (0.3)
    -0.01
    (0.6)
    2. Secondary Outcome
    Title Neurocognitive Testing (Stop Signal Reaction Time)
    Description stop signal reaction time is a measure of inhibitory control, where a shorter stop signal reaction time indicates greater inhibitory control.
    Time Frame 1 hour

    Outcome Measure Data

    Analysis Population Description
    [Not Specified]
    Arm/Group Title Diet Soda Soda Carbonated Water
    Arm/Group Description 12oz can of Diet Coke diet soda: 12 oz can of artificially sweetened cola beverage (Diet Coke planned to be used but similar to Diet Pepsi or other Diet Colas) 12oz can of Coke Regular soda: 12oz can of regular cola beverage (Coke planned but similar to Pepsi or other regular cola sodas) 12oz can of carbonated (unflavored) water Carbonated Water: 12oz can of carbonated water (sparking water, selzter water) unflavored
    Measure Participants 5 5 4
    Mean (Standard Error) [ms]
    162.6
    (12.5)
    172.9
    (17.4)
    180.2
    (19.9)

    Adverse Events

    Time Frame 3 weeks
    Adverse Event Reporting Description
    Arm/Group Title Diet Soda Soda Carbonated Water
    Arm/Group Description 12oz can of Diet Coke diet soda: 12 oz can of artificially sweetened cola beverage (Diet Coke planned to be used but similar to Diet Pepsi or other Diet Colas) 12oz can of Coke Regular soda: 12oz can of regular cola beverage (Coke planned but similar to Pepsi or other regular cola sodas) 12oz can of carbonated (unflavored) water Carbonated Water: 12oz can of carbonated water (sparking water, selzter water) unflavored
    All Cause Mortality
    Diet Soda Soda Carbonated Water
    Affected / at Risk (%) # Events Affected / at Risk (%) # Events Affected / at Risk (%) # Events
    Total 0/5 (0%) 0/5 (0%) 0/4 (0%)
    Serious Adverse Events
    Diet Soda Soda Carbonated Water
    Affected / at Risk (%) # Events Affected / at Risk (%) # Events Affected / at Risk (%) # Events
    Total 0/5 (0%) 0/5 (0%) 0/4 (0%)
    Other (Not Including Serious) Adverse Events
    Diet Soda Soda Carbonated Water
    Affected / at Risk (%) # Events Affected / at Risk (%) # Events Affected / at Risk (%) # Events
    Total 0/5 (0%) 0/5 (0%) 0/4 (0%)

    Limitations/Caveats

    [Not Specified]

    More Information

    Certain Agreements

    All Principal Investigators ARE employed by the organization sponsoring the study.

    There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.

    Results Point of Contact

    Name/Title Dr. Olivia Farr
    Organization Beth Israel Deaconess Medical Center
    Phone 6176678636
    Email ofarr@bidmc.harvard.edu
    Responsible Party:
    Olivia Farr, Instructor in Medicine, Beth Israel Deaconess Medical Center
    ClinicalTrials.gov Identifier:
    NCT04048681
    Other Study ID Numbers:
    • 2019P000649
    First Posted:
    Aug 7, 2019
    Last Update Posted:
    Feb 5, 2020
    Last Verified:
    Jan 1, 2020